CD63 and glioblastoma: CD63 expression on platelets in GBM patients was significantly increased by about 50% (GBM: median 2.7%, range from 0.6% to 4.4%/CON: median 1.8%, range from 0.3% to 3.7%/p = 0.01) (Figure 1A).